RADX
Radiopharm Theranostics
$1.12
+$0.17 (+17.47%)Oct 29, 2026
Key metrics
The numbers that frame RADX today
- Market cap
- $13.18M
- Gross margin
- 9.5%
- EV / Sales
- 14.7
- ROIC
- -206.4%
- Div yield
- 0%
- Debt / equity
- 1.0
- 52wk Low
- $0.90
- 52wk High
- $16.25
Growth
Revenue and earnings trend for RADX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RADX
Is Radiopharm Theranostics a good buy?
No. Radiopharm Theranostics has poor quality and poor momentum. Both signals point to a weaker setup. We think Radiopharm Theranostics is selling at a very high price.
What is the market capitalization of RADX?
Radiopharm Theranostics's market capitalization is $13.18M.
What is the 52-week high for RADX stock?
The 52-week high for Radiopharm Theranostics is $16.25. The current close of $1.12 is 93.1% below that high.
What is the 52-week low for RADX stock?
The 52-week low for Radiopharm Theranostics is $0.90. The current close of $1.12 is 24% above that low.
Does RADX stock pay dividends?
Radiopharm Theranostics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RADX?
Radiopharm Theranostics's Debt / Equity ratio is 1.04.